返回 Agenda
Session 8: Harnessing AI in Pharmacovigilance: Insights, Applications, and Impact
Session Chair(s)
Mariette Boerstoel-Streefland, MD, MBA, MS
Senior Vice President, Worldwide Safety Officer
Bristol-Myers Squibb Company, United States
After a more general overview of applicability of AI in PV, this session will share insights into what has emerged from the ongoing efforts in CIOMS XIV on the topic. After this, the audience will get deeper insights into two cases of successful leveraging of AI technology. The first is focused on increasing efficiency with literature review and case extraction, the second is on improved efficiencies in signal evaluation. This session is intended to increase understanding and stimulate thinking on where AI can help further our field of PV.
Learning Objective : - Discuss general principles of application of AI in PV
- Recognize advantages and caveats of AI in PV
- Identify what are and what aren’t good use cases for AI application
- Examine how to increase ability to judge what AI application does and what doesn’t make sense for their specific organization
Speaker(s)
CIOMS Working Group XIV – Artificial Intelligence in Pharmacovigilance
Representative Invited
FDA, United States
Updesh Dosanjh, MSc
IQVIA, United States
Practice Leader, Technology Solutions
Leveraging Intelligent Automation Improved Efficiency in Pharmacovigilance Signal Evaluation
Jeffrey Warner, PhD, MS
Eli Lilly and Company, United States
Post-Doctoral Scientist